Skip to main content
Caplight Logo









Paratus Sciences

Paratus Sciences

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://paratussciences.com/

Last Round

Series A

Feb 27, 2023

Total Funding Raised

$100M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Paratus Sciences is a biotechnology company that develops novel therapeutics by leveraging evolutionary insights from bat biology to address serious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverybiotechnologyAI drug discoverytherapeutic discoverytarget identificationin silico drug discoverybiotech R&Dknowledge graphmulti-omic datatherapeutic pipelineAI-native biotechdrug developmentcomputational biologybiopharma partnershiptarget validation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paratus Sciences Comparables

Compare Paratus Sciences with similar companies based on industry and business-model similarity.

Paratus Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fauna Bio
84%
Valo Health
81%
Odyssey
79%

Paratus Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 27, 2023

Key People

Founding team and executive leadership

Jeffrey Young

Chief Financial Officer

Executive Team

Paratus Sciences Investors

Notable investors and investment history

Paratus Sciences investors
InvestorRounds
EcoR1 CapitalSeries A
ARCH Venture PartnersSeries A
ClavystBioSeries A
ARCH Venture PartnersSeries A
Alexandria Venture InvestmentsSeries A
Polaris PartnersSeries A
Leaps by BayerSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 36% MoM.

  • Jul 1, 2026

    Grew 18% QoQ from 17 to 20 employees.

Paratus Sciences Filings

Explore SEC and related filing metadata, where available.

Paratus Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Paratus Sciences's valuation, stock price, and market status.

Is Paratus Sciences a public or private company?

Paratus Sciences is a private company.

What is the current stock price of Paratus Sciences?

Paratus Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Paratus Sciences worth (valuation)?

Valuation information for Paratus Sciences is not publicly available.

Can I buy Paratus Sciences stock?

Paratus Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Paratus Sciences's last funding round?

Paratus Sciences's most recent funding round was Series A on February 27, 2023.

Who are the main investors in Paratus Sciences?

Key investors in Paratus Sciences include EcoR1 Capital, ClavystBio, ARCH Venture Partners, Polaris Partners, Leaps by Bayer.

Will Paratus Sciences IPO soon?

No public IPO plans have been announced for Paratus Sciences.

How can I track Paratus Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paratus Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range20
Year Founded2021
Last FundingFeb 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?